Parnax Lab (PARNAXLAB) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
1.9B
Gross Profit
917.4M
48.86%
Operating Income
193.9M
10.33%
Net Income
115.4M
6.15%
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
1.1B
Shareholders Equity
832.4M
Debt to Equity
1.28
Cash Flow Metrics
Operating Cash Flow
297.4M
Free Cash Flow
137.2M
Revenue & Profitability Trend
Parnax Lab Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.9B | 1.9B | 1.7B | 1.6B | 900.6M |
| Cost of Goods Sold | 960.0M | 1.3B | 1.2B | 1.2B | 605.1M |
| Gross Profit | 917.4M | 554.3M | 512.7M | 480.2M | 295.5M |
| Operating Expenses | 405.4M | 463.1M | 71.7M | 67.8M | 49.8M |
| Operating Income | 193.9M | 166.7M | 167.5M | 172.1M | 49.9M |
| Pre-tax Income | 156.7M | 120.5M | 122.8M | 122.6M | -837.5K |
| Income Tax | 41.3M | 24.2M | 36.5M | 40.1M | 2.8M |
| Net Income | 115.4M | 96.2M | 86.3M | 82.6M | -3.6M |
| EPS (Diluted) | - | ₹8.37 | ₹7.79 | ₹9.68 | -₹0.43 |
Income Statement Trend
Parnax Lab Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 683.4M | 754.3M | 610.6M | 747.7M | 392.4M |
| Non-Current Assets | 1.2B | 1.1B | 840.1M | 787.0M | 670.2M |
| Total Assets | 1.9B | 1.9B | 1.5B | 1.5B | 1.1B |
| Liabilities | |||||
| Current Liabilities | 743.3M | 818.3M | 630.4M | 809.8M | 543.7M |
| Non-Current Liabilities | 322.4M | 352.4M | 197.7M | 242.1M | 192.6M |
| Total Liabilities | 1.1B | 1.2B | 828.1M | 1.1B | 736.4M |
| Equity | |||||
| Total Shareholders Equity | 832.4M | 716.9M | 622.6M | 482.8M | 326.2M |
Balance Sheet Composition
Parnax Lab Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 156.7M | 120.5M | 122.8M | 122.6M | -837.5K |
| Operating Cash Flow | 297.4M | 41.6M | 252.1M | -126.9M | 66.2M |
| Investing Activities | |||||
| Capital Expenditures | -70.4M | -319.3M | -100.2M | -178.2M | -44.8M |
| Investing Cash Flow | -77.5M | -319.3M | -100.4M | -181.6M | -46.5M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -177.8M | 201.6M | -183.0M | 173.6M | 87.6M |
| Free Cash Flow | 137.2M | -165.4M | 96.3M | -77.1M | -2.3M |
Cash Flow Trend
Parnax Lab Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.86
Price to Book
1.36
Price to Sales
0.61
Profitability Ratios
Profit Margin
6.14%
Operating Margin
9.80%
Return on Equity
14.90%
Return on Assets
6.40%
Financial Health
Current Ratio
0.92
Debt to Equity
83.52
Beta
0.41
Per Share Data
EPS (TTM)
₹10.05
Book Value per Share
₹72.57
Revenue per Share
₹163.80
Financial data is updated regularly. All figures are in the company's reporting currency.